Comprehensive genomic testing for specific cancer types
Genome Characterization Unit
This study is looking at the genes in tumor samples from patients with multiple myeloma, colorectal cancer, and cholangiocarcinoma to find out how their unique genetic changes can help guide their treatment, and patients will be followed over time to see how well the treatments are working.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10924009 on NIH RePORTER |
What this research studies
This research focuses on providing detailed genomic testing for patients diagnosed with multiple myeloma (MM), colorectal cancer (CRC), and cholangiocarcinoma (CHOL). It involves analyzing tumor samples alongside matched normal tissue to identify genetic mutations and alterations that may inform treatment options. The study employs advanced techniques such as whole exome sequencing, RNA sequencing, and targeted deep sequencing to ensure high-quality and accurate results. Patients will be monitored over time to assess disease progression and response to therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple myeloma, colorectal cancer, or cholangiocarcinoma.
Not a fit: Patients with other types of cancer or those not diagnosed with the specified conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment strategies for patients with these specific cancers.
How similar studies have performed: Previous research has shown success in utilizing genomic testing to improve cancer treatment outcomes, indicating that this approach is both promising and validated.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Ding, Li — Washington University
- Study coordinator: Ding, Li
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.